“All In” ASX Buy Alert
By: Bruce Jackson
Sometimes I have to pinch myself…
As General Manager of The Motley Fool Australia, every day I wake up and get the chance to live my lifelong dream — help everyday investors like you identify and hopefully profit from some of the world’s most promising investment opportunities.
And it’s times of uncertainty and confusion that really open the doors to some of the best opportunities available to investors like you and me.
It’s hard to believe, but 2020 marks the 27-year anniversary of the founding of The Motley Fool!
It’s truly amazing that we’ve gone from publishing an U.S. investment newsletter for 300 or so subscribers out of the shed behind our founder’s house…
To serving millions of hardworking investors like you in Australia and around the globe in countries as far-flung as Germany, the United Kingdom, Hong Kong, and Japan…
All while navigating the dot.com bubble, the GFC and now the Coronavirus fear.
It’s been a heck of a run — but what I’m most proud of is our ability to consistently lead investors like you to some of the most life-changing investment returns the market has ever seen. I’m talking, of course, about companies like:
- ResMed (up 455%)
- Corporate Travel Management (up 566%)
- Cochlear (up 270%)
- Seek (up 245%)
These are actual investment recommendations that have been shared with The Motley Fool community over the years – and the list goes on!
But I’m not here to take a victory lap or make you feel depressed if you missed out on any of these huge gains…
Instead, I’m writing to you today to talk about something I believe will change the way you invest forever.
More specifically, I’ve stumbled upon a little-owned opportunity I believe could be one of the greatest discoveries of my decades of being a professional investor.
I realise that’s a bold statement, so allow me to explain…
This under-the-radar ASX recommendation is virtually unknown among individual investors, and no wonder.
What it offers is an utterly unique strategy to position yourself to potentially profit alongside some of the world’s biggest and most powerful tech companies.
Until now, Australian investors have been SHUT OUT of the biggest global tech stories and the fortunes these companies have earned for their lucky shareholders. But everything’s different now. Just don’t expect the TV talking heads to tell you…
While everyone in the Australian Financial Review and The Sydney Morning Herald is busy talking about blue-chip stocks like BHP and Commonwealth Bank, this underfollowed play is quietly helping thousands of Australians to get the global tech exposure they crave… and that they know will help them profit over the long term.
Potential returns of 1X, 2X and even 3X are all in play. Best of all, you could hold onto this little-known equity for DECADES to come.
That’s why, for the past several months, I’ve been pounding the table on this “All In” recommendation I’ve begun to tell you about today – urging members of The Motley Fool investment community to buy shares before they potentially skyrocket.
Look, I understand this all may sound too good to be true…
Which is exactly why I want to show you the hard numbers behind this incredible opportunity and invite you to hear more about this strategy directly from my team of analysts – that way, you can decide for yourself if you want to buy shares of this exciting play for your portfolio.
There’s just one catch:
I’m sharing the details of this recommendation ONLY with members of The Motley Fool’s flagship investing service, Motley Fool Share Advisor.
Now, if you’re not familiar with the Motley Fool Share Advisor service, it’s the online investing service that was created to provide easy-to-follow, monthly stock recommendations to individual investors.
That’s right! Each and every month, members tune in to discover which ASX stocks our own Scott Phillips believes investors should be buying shares of today.
Which brings me back to the “All In” ASX recommendation I’m banging on about today…
Because Scott Phillips wants as many investors as possible to potentially profit from this one of a kind opportunity, he has published a comprehensive “buy” report inside Share Advisor that shows you exactly why this is an “all in” buy.
Even better, because I’m completely convinced you’ll be impressed by the exclusive research Scott has put together, I’ll make sure your Share Advisor membership is backed by a guarantee that allows you to get your 100% of your membership fee back inside the first 30 days if you aren’t impressed or ultimately decide Share Advisor isn’t right for you!
That’s right, you can sign up for Share Advisor today, get the full details on this “All In” buy alert, and then get your full membership fee back within 30 days if you aren’t completely satisfied.
This is your chance to get in early on what could prove to be a very special investment recommendation.
Think about how many investing trends you’ve missed out on even though you knew they were going to be big.
Don’t let that happen again. This is your chance to get in early.
I urge you to take action today and decide for yourself if you want to take advantage of this potentially once-in-a-generation buying opportunity. Simply enter your email address below to access our secure sign-up page.
Returns as of 21st August 2020. The Motley Fool owns shares of Corporate Travel Management and Cochlear Limited. For more information about The Motley Fool see our Financial Services Guide. All returns cited are hypothetical and based on the percentage change between the stock price at the time of recommendation and the current or sell price (if the position has been closed) at the time of publication. Brokerage, taxes and any other associated costs are not taken into account. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. Performance figures are not intended to be a forecast and The Motley Fool does not guarantee the performance of, or returns on any investment. Any money back guarantee is strictly limited to the subscription price paid for the product.